Insiders / Menzel Garry E
Menzel Garry E
CIK 1556064personinsider
Companies
4
First seen
Jan 27, 2021
Last activity
Jun 29, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Tcr2 Therapeutics Inc. · TCRR | 0 | — |
| Adaptimmune Therapeutics PLC · ADAP | — | — |
| Black Diamond Therapeutics, Inc. · BDTX | — | — |
| Stoke Therapeutics, Inc. · STOK | — | — |
All securities held
8 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Adaptimmune Therapeutics PLC | Depositary shares | 275,703 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Adaptimmune Therapeutics PLC | Options | 1,121,604 |
| Black Diamond Therapeutics, Inc. | Options | 40,000 |
| Stoke Therapeutics, Inc. | Options | 29,747 |
Other
| Company | Security | Shares |
|---|---|---|
| Black Diamond Therapeutics, Inc. | Unclassified | 15,000 |
| Stoke Therapeutics, Inc. | Unclassified | 11,650 |
| Tcr2 Therapeutics Inc. | Unclassified | 180,932 |
| Tcr2 Therapeutics Inc. | Unclassified | 138,031 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Dec 9, 2021 | Exercise Option exercise | TCRR Tcr2 Therapeutics Inc. Common Stock | $129.5K | +175K +3882.85% | 179,507 | low |
| Jul 10, 2023 | Sell Open-market sale | ADAP Adaptimmune Therapeutics PLC American Depositary Shares representing Ordinary Shares | $43.4K | -48K -38.86% | 75,056 <0.01% of shares | low |
| Dec 6, 2022 | Sell Open-market sale | TCRR Tcr2 Therapeutics Inc. Common Stock |